Literature DB >> 6364439

Therapeutic aerosols 1--physical and practical considerations.

S P Newman, S W Clarke.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6364439      PMCID： PMC459691          DOI： 10.1136/thx.38.12.881

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  38 in total

1.  Method of using pressurized aerosols.

Authors:  C K Connolly
Journal:  Br Med J       Date:  1975-07-05

2.  Aerosol penetrance: a sensitive index of peripheral airways obstruction.

Authors:  M B Dolovich; J Sanchis; C Rossman; M T Newhouse
Journal:  J Appl Physiol       Date:  1976-03       Impact factor: 3.531

Review 3.  Deposition of inhaled aerosols.

Authors:  B O Stuart
Journal:  Arch Intern Med       Date:  1973-01

4.  The fate of ( 14 C)disodium cromoglycate in man.

Authors:  S R Walker; M E Evans; A J Richards; J W Paterson
Journal:  J Pharm Pharmacol       Date:  1972-07       Impact factor: 3.765

5.  Deposition of aerosols in pulmonary disease.

Authors:  I S Goldberg; R V Lourenço
Journal:  Arch Intern Med       Date:  1973-01

6.  Measurement of pulmonary air spaces using aerosols.

Authors:  E D Palmes
Journal:  Arch Intern Med       Date:  1973-01

7.  Dry powder aerosols. I. A new powder inhalation device.

Authors:  J H Bell; P S Hartley; J S Cox
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

8.  The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract.

Authors:  M Lippmann; R E Albert
Journal:  Am Ind Hyg Assoc J       Date:  1969 May-Jun

9.  Survey of the clinical use of pressurized aerosol inhalers.

Authors:  S W Epstein; C P Manning; M J Ashley; P N Corey
Journal:  Can Med Assoc J       Date:  1979-04-07       Impact factor: 8.262

10.  Effect of lung function and mode of inhalation on penetration of aerosol into the human lung.

Authors:  D Pavia; M L Thomson; S W Clarke; H S Shannon
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139
View more
  22 in total

1.  Pharmaceutical dry powder aerosols: correlation of powder properties with dose delivery and implications for pharmacodynamic effect.

Authors:  N M Concessio; M M VanOort; M R Knowles; A J Hickey
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  Delivery of propellant soluble drug from a metered dose inhaler.

Authors:  H L Ashworth; C G Wilson; E E Sims; P K Wotton; J G Hardy
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

Review 3.  Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions.

Authors:  Charlotte Roy; Manon Launay; Sophie Magréault; Isabelle Sermet-Gaudelus; Vincent Jullien
Journal:  Clin Pharmacokinet       Date:  2021-01-24       Impact factor: 6.447

4.  Inhalation treatment for asthma.

Authors:  J Reiser; J O Warner
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

5.  Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery.

Authors:  Mehdi Hassanpour Aghdam; Saeed Ghanbarzadeh; Yousef Javadzadeh; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2016-03-17

6.  Chapter 9 - Nanoliposomal dry powder formulations.

Authors:  Gaurang Patel; Mahavir Chougule; Mandip Singh; Ambikanandan Misra
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

7.  Evaluation of jet nebulisers for use with gentamicin solution.

Authors:  S P Newman; P G Pellow; M M Clay; S W Clarke
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

8.  The influence of actuator materials and nozzle designs on electrostatic charge of pressurised metered dose inhaler (pMDI) formulations.

Authors:  Yang Chen; Paul M Young; David F Fletcher; Hak Kim Chan; Edward Long; David Lewis; Tanya Church; Daniela Traini
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

9.  Investigation into alternative sugars as potential carriers for dry powder formulation of budesonide.

Authors:  Mohammed-Nurul Momin; Atoosa Hedayati; Ali Nokhodchi
Journal:  Bioimpacts       Date:  2011-08-05

10.  Efficacy of cromoglycate in persistently wheezing infants.

Authors:  S Furfaro; S Spier; S P Drblik; J P Turgeon; M Robert
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.